Non-protein nitrogen in feed market to surpass the billion-dollar benchmark by 2024, Urea to drive the product matrix
Endorsing a wide application scope in fodder business space, the profitability quotient of non-protein nitrogen in feed market is projected to substantially upscale in the coming years. Over the past few years, animal nutrition has managed to grab a bigger role than anticipated. Manufacturers across the world have been increasingly investing in R&D activities to develop a palate of new protein sources which expectedly would widen up the non-protein nitrogen in feed industry opportunities. In this regard, it is prudent to mention that protein-rich leguminous fodders are usually not extensively grown in many areas, which are prone to attack by ruminants, as they are comparatively more expensive than non-protein nitrogen sources. The growth of non-protein nitrogen in feed industry can be fundamentally credited to this factor. Global Market Insights Inc., forecasts the overall non-protein nitrogen in feed market size to record a valuation of over USD 1 billion by 2024.
U.S. Non-protein nitrogen in feed market, By Product, 2013-2024, (Kilo Tons)
Speaking of commercialization potential of non-protein nitrogen in feed industry, it is nothing but enormous. The increasing consumption of meat bears an evidence to the fact. As per estimates by WHO, annual meat production will surpass 376 million tons by the end of 2030, which is an exceptional rise from that recorded in the year 1999- 218 million tons. The world population presently consumes 75 pounds of meat per person annually, as cited by the Organization for Economic Cooperation & Development. The sharp incline in the meat consumption has undoubtedly left a perpetual impact on the demand for non-protein nitrogen in feed market. A recent report brought forth by U.S. Food and Agriculture Organization claims that global meat production will be 16% higher in 2025, from that what it recorded over 2013-2015. These statistics quite profoundly depicts the increasing pressure on livestock breeding to address the increasing demand for animal nutrition, indirectly leaving a subsequent impact on non-protein nitrogen in feed market share.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/2134
The most common non-protein nitrogen source which is extensively deployed in ruminant feeding is urea. Though there are other sources that have been experimentally and commercially deployed, urea holds quite a prominent position in the global industry landscape. Estimates depict, overall non-protein nitrogen in feed market share from urea accounted for a revenue of USD 550 million in 2016. Some of the prime factors that have driven non-protein nitrogen in feed market share from urea include higher nitrogen content of almost 46.7%, reduced live weight loss, low cost, and increased intake of dry roughage. In addition to this, being the building blocks of non-protein sources, it can be easily fed to ruminants as a replacement for a part of protein in a ration. The ability of micro-organisms present in the rumen of sheep and cattle to utilize these non-protein sources or urea eradicates the requirement of imported protein supplements, with no hazardous impact on animal health. Having procured almost 75% of the overall non-protein nitrogen in feed industry share, urea is slated to drive the product landscape in the coming years. However, urea toxicity and stringent regulatory framework pertaining to its production in some areas might hamper the industry growth to some extent.
However, changing healthcare dynamics and food preferences are some of the pivotal factors providing a significant push to the global non-protein nitrogen in feed industry trends. In this regard, Asia Pacific has established a strong foothold in the worldwide fraternity, with increasing proliferation of advanced technology for effective synthesis of protein from non-protein sources. In fact, estimates claim a humongous portion of urea to be consumed in Asian countries like India, China, and Japan, to maintain and boost livestock health and nutrition, particularly ruminants. A subsequent rise in research investments from international producers as well as spreading awareness regarding the usage of nutritious forage has led APAC non-protein nitrogen in feed industry size to record a valuation USD 400 million in 2016. The exponential rise in the livestock population over the past couple of years will certainly propel the regional market demand to great heights in the years ahead.
Worldwide, non-protein nitrogen in feed industry encompasses a host of renowned biggies including Yara International ASA, Incitec Pivot, Archer Daniels Midland Company, The Potash Corporation of Saskatchewan, and Borealis. The marketplace seems to be pretty much consolidated with leading giants’ relentless effort in strengthening their business position by underlying various growth strategies such as joint ventures, product differentiation, production capacity expansion etc. An upswing in global meat production, subject to its increased consumption undeniably remains one of the principal factors driving non-protein nitrogen in feed market size. Moreover, the expansion in supply chain and technological advancements with regards to product manufacturing are further expected to carve a lucrative roadmap for non-protein nitrogen in feed industry over the ensuing years.
Author Name : Satarupa De
Digital genome market to observe lucrative gains via R&D sector, U.S. to stimulate industry growth over 2016-2024
On-going research activities along with supportive regulations across the globe will revolutionize digital genome market. The growing implementation of this technology in the field of personalized medical care for efficient disease management will noticeably favor digital genome industry share. According to the Global Market Insights, “Worldwide digital genome market was worth USD 20 billion in 2015 and will exhibit a CAGR of about 9.5% over the coming years of 2016 to 2024.”
The prominent applications of digital genome industry are microbiology, reproductive & genetic, research & development, transportation, and livestock & agriculture sectors. Microbiology application segment accounted for more than 22% of the revenue share in 2015 and will surpass a revenue collection of USD 10 billion by 2024. The growing demand for microbes across clinical, biological, and industrial sectors should drive the revenue. Research & development dominated the application landscape in 2015 and will contribute a revenue of more than USD 23 billion by 2024. The growth can be attributed to heavy investments by private and public sector firms in research activities.
Germany Digital Genome Market size, by product, 2012-2024 (USD Million)
Sequencing and analysis software, one of the product bifurcations of digital genome market, will register an annual growth rate of 9.8% over the period of 2016 to 2024, owing to the increasing efforts to upgrade software packages. High investments in life science research will favor sequencing and analyzer instrument industry, which covered more than 40% of the global digital genome market contribution in 2015. Sample prep instruments, sequencing chip, and RNA or DNA analysis kits are the other notable products in digital genome industry.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1219
China digital genome market size will grow at an annual growth rate of more than 10% over the period of 2016 to 2024. The growth can be attributed to the supportive governmental activities in the favor of human genetic development. Moreover, the strategic partnerships between the biobanks and research institutes will influence the industry share noticeably.
U.S. digital genome market covered over 80% of the North America regional share in 2015 and will generate significant revenue over the coming seven years, owing to the genome sequencing technological enhancements along with availability of advanced healthcare infrastructure.
Brazil digital genome market is anticipated to record a considerable growth rate over the coming timeframe. The supportive rules and regulations regarding genetic and clinical testing will augment the business growth.
Russia digital genome market collected a revenue of around USD 290 million in 2015 and will exhibit lucrative growth over the coming years of 2016 to 2024, primarily driven by the fierce competition prevalent in the region. The Genome Russia project launched by St. Petersburg State University in Russia, aims to collect and scrutinize genome sequences from different regions across the country, which is also expected to generate a noticeable revenue over the coming seven years.
Collaborations, acquisitions, and novel product innovations are the business growth strategies of industry giants. The corporations operating in digital genome market are Becton Dickinson, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Illumina, Pacific Biosciences, Perkin Elmer, Sigma-Aldrich, BioMarin Pharmaceutical, Fluidigm Corporation, Bio-Reference Laboratories, AVEO Oncology, and Agios.
Author Name :Sunil Hebbalkar